Duncan Williams Asset Management, LLC Apellis Pharmaceuticals, Inc. Call Options Transaction History
Duncan Williams Asset Management, LLC
- $181 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding APLS
# of Institutions
303Shares Held
112MCall Options Held
5.03MPut Options Held
703K-
Wellington Management Group LLP Boston, MA16.4MShares$463 Million0.11% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$328 Million15.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$314 Million4.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$277 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$164 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.1B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...